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et al., 1986; Rees et al., 2007). One 
mechanism that may explain this 
effect is the apparent ability of caf-
feine to selectively induce apoptosis in 
UV-damaged keratinocytes. “Normal” 
human skin carries clonal patches of 
p53-mutated keratinocytes. These are 
enriched by sun exposure, indicating 
that p53-mutated keratinocytes may 
be more resistant to UV-induced apop-
tosis (Jonason et al., 1996). Crucially, 
caffeine-induced potentiation of apop-
tosis in this context appears to be inde-
pendent of p53. The biological effects 
of caffeine are complex. Caffeine (in 
amounts in the millimolar range) can 
inhibit both ATR and the related ataxia-
telangiectasia-mutated (ATM) kinase, 
both of which are central components 
of the DNA damage response. ATM 
is activated by DNA double-strand 
breaks, whereas ATR is preferentially 
activated by single-stranded regions 
of DNA, which can occur at stalled 
DNA replication forks or as intermedi-
ates during NER of UV photoproducts 
(O’Driscoll et al., 2003). But much 
of the work concerning caffeine and 
ATR/ATM has traditionally used either 
primary and transformed fibroblasts or 
tumor-derived cell lines such as HeLa, 
293T, and U2OS.
In this issue, Heffernan and col-
leagues report the combined impact of 
caffeine and UVB radiation on a phys-
iologically relevant target, namely, 
primary human keratinocytes (HKCs). 
This is important not only because 
nonmelanoma skin cancers arise from 
these cells but also because keratino-
cytes respond to UVB differently than 
do skin fibroblasts, as discussed in 
Heffernan et al. The authors report that 
caffeine (2 mM) induced an apoptotic 
response following UVB irradiation 
at 75 mJ/cm within 8 hours, as indi-
cated by caspase-3 and PARP cleav-
age. Caffeine is also a known inhibitor 
kinase ATR (ataxia telangiectasia and 
Rad3-related). Mutations in ATR in 
humans are associated with Seckel 
syndrome, a developmental disor-
der characterized by microcephaly 
and proportionate growth retardation 
(O’Driscoll et al., 2003). ATR-mutated 
Seckel syndrome primary skin fibro-
blasts exhibit decreased survival 
following UV irrad iation (O’Driscoll 
et al., 2003). ATR phosphorylates sev-
eral proteins, including the histone 
H2A variant H2AX, p53, and Brca1. 
Chk1 kinase is an important effector 
and substrate of ATR. Chk1 plays a key 
role in mediating replication fork sta-
bility following DNA damage and is 
also required for cell cycle checkpoint 
activation (Chen and Sanchez, 2004). 
In fact, selective inhibitors of Chk1, 
such as UCN-01, are being investi-
gated in the clinic for combinational 
therapies with other DNA-damaging 
agents against various malignancies.
There is growing molecular, cellu-
lar, and epidemiological evidence to 
suggest that caffeine, even in its most 
recognizable form in tea and cof-
fee, may have a significant protective 
effect against UV-induced carcinogen-
esis in mice and humans (Abel et al., 
2007; Hakim et al., 2000; Jacobsen 
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Relentless depletion of the ozone 
layer, climate change, increased 
recreational sun exposure, and even 
the use of UV tanning beds probably 
contribute to the increasing inci-
dence of nonmelanoma skin cancer. 
Much of the mutagenic and carci-
nogenic potential of UV radiation 
is a consequence of DNA damage 
(e.g., 6-4 pyrimidine–pyrimadone 
photoproducts and cyclobutane 
pyrimidine dimers). These forms of 
DNA damage are efficiently recog-
nized and removed by the nucleotide 
excision repair (NER) pathway, a DNA 
repair pathway conserved from bacte-
ria to humans. Congenital defects in 
this pathway in humans result in a vari-
ety of complex disorders, including 
xeroderma pigmento sum, Cockayne’s 
syndrome, and trichothiodystrophy, 
all of which feature sunlight sensi-
tivity and, particularly in the case of 
xeroderma pigmentosum, a predis-
position to cancer in sun-exposed 
areas. UV-induced DNA damage also 
induces multiple signal transduction 
networks that coordinate cell cycle 
checkpoint arrest and even apopto-
sis induction. An important pathway 
activated in response to UV is the 
phosphoinositol-3-kinase-like protein 
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The incidence of sunlight-induced skin cancer is increasing. Mouse studies 
indicate that caffeine, administered orally or topically, promotes apoptosis of 
UVB-irradiated keratinocytes. In this issue, Heffernan and colleagues iden-
tify the pathway targeted by caffeine and suggest that inhibition of this DNA 
damage response may offer a viable therapeutic option for nonmelanoma 
skin cancer. This potentially represents an important protective or therapeu-
tic option from the most unlikely of sources: your daily coffee.
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of cAMP phosphodiesterase, which, 
when inhibited, results in increased 
intra cellular levels of cAMP.
Using dibutyryl-cAMP, a cell-
 permeable  cAMP analog, Heffernan and 
colleagues determined that the apop-
totic effects of caffeine following UVB 
in HKCs are unlikely to be mediated via 
cAMP phosphodiesterdase inhibition. 
Not surprisingly, they reported that 
UVB activates the ATR-Chk1 pathway 
in HKCs (Figure 1), as indicated by 
increased phospho-serine-345-Chk1. 
Interestingly, this phosphorylation 
was attenuated by caffeine. In fact, 
siRNA of ATR, but not that of the relat-
ed kinase ATM, in HKCs augmented 
UVB-induced apoptosis, mimicking 
the effect of caffeine in these cells. 
Importantly, caffeine did not fur-
ther enhance UVB-induced apopto-
sis following siRNA of ATR in HKCs, 
indicating that caffeine’s effects are 
epistatic to those of ATR-pathway 
inhibition. Furthermore, Heffernan 
and colleagues reported that treat-
ment of HKCs with PF610666, a novel 
Chk1 kinase inhibitor that appears to 
be more selective than UCN-01, the 
archetypal Chk1 inhibitor, similarly 
potentiated UVB-induced apoptosis 
(Heffernan et al., 2009; Blasina et al., 
2008). Collectively, these data strongly 
indicate that the ATR–Chk1 pathway 
may represent the main biologically 
relevant target of caffeine in HKCs.
Of particular note, Heffernan et al. 
also reported that the ability of ATR 
inhibition to enhance UVB-induced 
apoptosis was independent of p53 
status in HKCs, raising the intrigu-
ing suggestion that administration of 
an ATR-pathway inhibitor, such as a 
selective Chk1 inhibitor or, indeed, 
caffeine, may provide protection 
against the DNA-damaging impact of 
UVB on skin. In support of this, Lu et 
al. (2008) recently demonstrated that 
oral administration of caffeine in milli-
molar concentrations to mice markedly 
inhibited UVB-induced Chk1 phospho-
rylation on serine 345 in the epidermis, 
indicating that, at least in this animal 
model, the ATR-Chk1 pathway can be 
inhibited in the relevant target tissue by 
administration of caffeine at tolerable 
doses. Previously, Lu et al. (2002) had 
demonstrated that topical application 
of caffeine to mice enhanced the elimi-
nation of p53-mutated keratinocytes 
from skin. The work by Heffernan et 
al. described in this issue provides a 
molecular explanation for these impor-
tant observations.
This apparent paradox raised by 
Heffernan and colleagues—that of 
inhibiting a DNA-damage response 
pathway to protect against the adverse 
impact of a DNA-damaging agent 
(i.e., UVB)—should stimulate inves-
tigation of the practical applications 
of ATR-pathway inhibition in HKCs 
for the prevention of nonmelanoma 
skin cancer. An inborn deficit in ATR-
pathway function results in a severe 
developmental disorder in humans. 
Whereas gene targeting of ATR in 
mice results in early embryonic lethal-
ity prior to gastrulation, indicating the 
essential role of ATR during develop-
ment, knockdown of ATR in somatic 
cells results in pronounced genomic 
instability, particularly DNA fragile-
site expression. Indeed, conditional 
deletion of ATR in adult mice has a 
profound impact on the homeostasis 
of many different tissues, including 
skin, indicating that there may be a 
long way to go before we can deter-
mine the precise conditions whereby 
ATR-pathway inhibition is protective 
or beneficial (Ruzankina et al., 2007). 
Nevertheless, the suggestion prof-
fered by Heffernan and colleagues of 
a topical formulation containing an 
ATR-Chk1 pathway inhibitor applied 
directly to the target tissue (i.e., skin) 
cleverly circumvents the potential 
“off-target” side effects that would be 
predicted by a systemic inhibition of 
this important DNA-damage response 
pathway.
Considering the role of ATR in 
maintaining genomic stability, the 
long-term impact of ATR-pathway 
inhibition in HKCs, specifically with 
respect to potential secondary tumor 
formation, is one issue that will need 
to be addressed, but the work by 
Heffernan and colleagues provides a 
definite starting point. Ironically, one 
important compound that could help 
here has been under our noses for 
years, namely, caffeine.
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figure 1. UVB irradiation activates the ATR–chk1 pathway in primary human keratinocytes 
(HKcs). ATR–Chk1 pathway activation normally results in cell cycle checkpoint activation. Caffeine 
selectively enhances UVB-induced apoptosis in HKCs by inhibiting the ATR–Chk1 pathway. 
Selective inhibition of Chk1 kinase using PF610666 mimics the effect of caffeine in these cells. 
UVB irradiation has been shown to enhance selection for p53-mutated HKCs in sun-exposed skin 
(cells with black nuclei). Because UV-induced transformation of HKCs results in nonmelanoma skin 
cancer, the findings of Heffernan and colleagues raise the intriguing possibility that application of an 
ATR-pathway inhibitor such as caffeine may be protective against UVB radiation by augmenting the 
apoptotic elimination of UVB-damaged HKCs independently of p53 status (gray cells).
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